Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

German Ott

Showing results (271-280 of 374) with videos related to

Pageof 38
Sort By:
British Journal of Haematology|December 20, 2018
Differential expression of long non-coding RNAs are related to proliferation and histological diversity in follicular lymphomasAlejandro Roisman, Giancarlo Castellano, Alba Navarro, et al.
Plos One|July 9, 2011
Epigenetic activation of SOX11 in lymphoid neoplasms by histone modificationsMaria Carmela Vegliante, Cristina Royo, Jara Palomero, et al.
Cancer Cell|April 13, 2016
Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell LymphomaYibin Yang, Priscilla Kelly, Arthur L Shaffer, et al.
Blood|December 21, 2012
CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphomaItziar Salaverria, Cristina Royo, Alejandra Carvajal-Cuenca, et al.
Virchows Archiv : an International Journal of Pathology|February 2, 2021
Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic featuresSietse M Aukema, Giorgio A Croci, Susanne Bens, et al.
Blood|February 17, 2017
Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCLTabea Erdmann, Pavel Klener, James T Lynch, et al.
Science (New York, N.Y.)|March 8, 2008
Oncogenic CARD11 mutations in human diffuse large B cell lymphomaGeorg Lenz, R Eric Davis, Vu N Ngo, et al.
The American Journal of Surgical Pathology|May 15, 2026
Challenges in Diagnosing High-grade B-cell Lymphoma, NOS: Poor Interobserver Agreement on Its Morphologic Definition-An LLMPP StudyKatrin S Kurz, Sarah L Ondrejka, Brett Collinge, et al.
Nature Cancer|January 17, 2025
First-in-class ultralong-target-residence-time p38α inhibitors as a mitosis-targeted therapy for colorectal cancerRamona Rudalska, Jule Harbig, Michael Forster, et al.
Blood Advances|September 17, 2020
Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk modelsStefan Alig, Vindi Jurinovic, Mohammad Shahrokh Esfahani, et al.
Pageof 38

Showing results (271-280 of 374) with videos related to

Sort By:
Pageof 38
British Journal of Haematology|December 20, 2018
Differential expression of long non-coding RNAs are related to proliferation and histological diversity in follicular lymphomasAlejandro Roisman, Giancarlo Castellano, Alba Navarro, et al.
Plos One|July 9, 2011
Epigenetic activation of SOX11 in lymphoid neoplasms by histone modificationsMaria Carmela Vegliante, Cristina Royo, Jara Palomero, et al.
Cancer Cell|April 13, 2016
Targeting Non-proteolytic Protein Ubiquitination for the Treatment of Diffuse Large B Cell LymphomaYibin Yang, Priscilla Kelly, Arthur L Shaffer, et al.
Blood|December 21, 2012
CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphomaItziar Salaverria, Cristina Royo, Alejandra Carvajal-Cuenca, et al.
Virchows Archiv : an International Journal of Pathology|February 2, 2021
Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic featuresSietse M Aukema, Giorgio A Croci, Susanne Bens, et al.
Blood|February 17, 2017
Sensitivity to PI3K and AKT inhibitors is mediated by divergent molecular mechanisms in subtypes of DLBCLTabea Erdmann, Pavel Klener, James T Lynch, et al.
Science (New York, N.Y.)|March 8, 2008
Oncogenic CARD11 mutations in human diffuse large B cell lymphomaGeorg Lenz, R Eric Davis, Vu N Ngo, et al.
The American Journal of Surgical Pathology|May 15, 2026
Challenges in Diagnosing High-grade B-cell Lymphoma, NOS: Poor Interobserver Agreement on Its Morphologic Definition-An LLMPP StudyKatrin S Kurz, Sarah L Ondrejka, Brett Collinge, et al.
Nature Cancer|January 17, 2025
First-in-class ultralong-target-residence-time p38α inhibitors as a mitosis-targeted therapy for colorectal cancerRamona Rudalska, Jule Harbig, Michael Forster, et al.
Blood Advances|September 17, 2020
Evaluating upfront high-dose consolidation after R-CHOP for follicular lymphoma by clinical and genetic risk modelsStefan Alig, Vindi Jurinovic, Mohammad Shahrokh Esfahani, et al.
Pageof 38